Kyle Hvidsten is the Head of Sanofi’s Specialty Care Health Economics and Value Assessment department. In this role, Kyle oversees input into clinical trial design and the development of economic models and RWE studies to generate peer-reviewed publications, technical submissions and scientific exchanges with health technology assessment agencies and healthcare payer organizations around the globe. Prior to joining Sanofi, Kyle held several positions in US and Global health economics and outcomes research with increasing levels of responsibility over the past 20+ years. He holds a MPH degree from Columbia University and a BA from Emory University.
Speaking In
11:00 AM - 12:00 PM
Tuesday, June 6